I

IMCR

Immunocore Holdings Plc

30.16

-0.20-0.66%
After Hours: 29.57  -0.59  -1.96%16:07 04/25 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

310.20M

249.43M

143.74M

26.52M

30.11M

Net Income

-51.09M

-55.29M

-41.22M

-131.52M

-74.09M

ROE

-0.14

-0.1562

-0.147

-0.8955

-1.6325

ROA

-0.0636

-0.0984

-0.0899

-0.4072

-0.299

EPS

-1.0219

-1.1309

-0.9018

-3.0955

-1.7518

BVPS

7.205

7.4176

128.758

206.278

1.3085

Asset Turnover

0.3862

0.4439

0.3133

0.0821

0.1215

Debt-to-Asset

0.6427

0.3822

0.3599

0.4315

0.7193

Current Ratio

4.3824

3.8039

4.7163

4.2943

2.7807

Quick Ratio

4.3567

3.7715

4.705

--

--